Odyssey Health (ODYY) Other Non-Current Assets (2017 - 2022)
Odyssey Health's (ODYY) quarterly Other Non-Current Assets came in at $366475.0 in Q3 2022, up 747.34% quarter-over-quarter from $43250.0 in Q2 2017.
Odyssey Health (ODYY) Other Non-Current Assets (2017 - 2022) Analysis & Trends
Odyssey Health's Other Non-Current Assets history runs 2 years deep, the most recent figure standing at $366475.0 for Q3 2022.
- On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $366475.0 in Q3 2022; TTM through Jul 2022 was $366475.0, a N/A change from a year earlier, with the FY2022 full-year figure at $366475.0, changed N/A from the prior year.
- Other Non-Current Assets advanced to $366475.0 in Q3 2022 per ODYY's latest filing, from $43250.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $366475.0 in Q3 2022 and bottomed at $366475.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2022 | 366,475.00 |
| Apr 30, 2017 | 43,250.00 |
| Jan 31, 2017 | 5.02 Mn |